Going global with sepsis: The need for national registries

Critical Care Medicine

Volumn 37, Issue 1, 2009, Pages 338-340

  Cribbs, Sushma K ^a   Martin, Greg S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; International The authors have not disclosed any potential conflicts of interest.; Sepsis

Indexed keywords

CAUSE OF DEATH; DISEASE SEVERITY; EDITORIAL; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REGISTER; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; HEALTH; NOTE;

HUMANS; REGISTRIES; SEPSIS; WORLD HEALTH;

EID: 59649100066     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181934fab     Document Type: Editorial

References (23)

1. Alberti C, Brun-Buisson C, Chevret S, et al: Systemic inflammatory response and progression to severe sepsis in critically ill infected patients. Am J Respir Crit Care Med 2005; 171:461-468
2. Brun-Buisson C, Doyon F, Carlet J, et al: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995; 274:968-974
3. Brun-Buisson C, Meshaka P, Pinton P, et al: EPISEPSIS: A reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30:580-588
4. Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554
5. Padkin A, Goldfrad C, Brady AR, et al: Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31:2332-2338
6. Heyland DK, Hopman W, Coo H, et al: Long-term health-related quality of life in survivors of sepsis. Short Form 36: A valid and reliable measure of health-related quality of life. Crit Care Med 2000; 28:3599-3605
7. Perl TM, Dvorak L, Hwang T, et al: Long-term survival and function after suspected gramnegative sepsis. JAMA 1995; 274:338-345
8. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-1655
9. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
10. Finfer S, Bellomo R, Lipman J, et al: Adultpopulation incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med 2004; 30:589-596
11. Engel C, Brunkhorst FM, Bone HG, et al: Epidemiology of sepsis in Germany: Results from a national prospective multicenter study. Intensive Care Med 2007; 33: 606-618
12. Esteban A, Frutos-Vivar F, Ferguson ND, et al: Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward. Crit Care Med 2007; 35:1284-1289
13. Sundararajan V, Macisaac CM, Presneill JJ, et al: Epidemiology of sepsis in Victoria, Australia. Crit Care Med 2005; 33:71-80
14. Vincent JL, Sakr Y, Sprung CL, et al: Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34: 344-353
15. Martin CM, Priestap F, Fisher H: A prospective, observational registry of patients with severe sepsis: The Canadian Sepsis Treatment and Response Registry. Crit Care Med 2009; 37:81-88
16. Alberti C, Brun-Buisson C, Burchardi H, et al: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28: 108-121
17. Parrillo JE, Parker MM, Natanson C, et al: Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113:227-242
18. Available at: http://www.nih.gov/news/ fundingresearchareas.htm. Accessed May 2, 2008
19. Available at: http://www.cdc.gov/nchs/ pressroom/data/state-mortality- rank-05.htm. Accessed May 2, 2008
20. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
21. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al: Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31:2742-2751
22. Leibovici L, Shraga I, Drucker M, et al: The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-386
23. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709